CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 trials EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification Left main coronary angioplasty: early and late results of 127 acute and elective procedures Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension
|<<... 135 136 137 138 139 140 141 ...>>|

Review Article2019 Feb;124(3):364-385.

JOURNAL：Circ Res. Article Link

Cholesterol-Lowering Agents

Rosenson RS, Hegele RA, Koenig W. Keywords: cardiovascular disease; cholesterol; myocardial infarction; patients; subtilisin

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top